Literature DB >> 21512445

Salidroside attenuates hydrogen peroxide-induced cell damage through a cAMP-dependent pathway.

Shuang Guan1, Wei Wang, Jing Lu, Wenhui Qian, Guoren Huang, Xuming Deng, Xuelin Wang.   

Abstract

Salidroside, a major component of Rhodiola rosea L., has shown various pharmacological functions, including antioxidant effects, but the signal transduction pathway of its antioxidant effects is not very clear. In this study, we found that salidroside could attenuate hydrogen peroxide (H(2)O(2))-induced HL-7702 cell damage, inhibit H(2)O(2)-induced cytosolic free Ca2+ ([Ca2+]i) elevation, scavenge reactive oxygen species (ROS) and increase 3'-5'-cyclic adenosine monophosphate (cAMP) level in a dose-dependent manner, but it couldn't influence 3'-5'-cyclic guanosine monophosphate (cGMP) levels. Therefore, these results indicated that the antioxidant effects of salidroside were associated with down-regulation of [Ca2+]i, ROS occur via a cAMP-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21512445      PMCID: PMC6260613          DOI: 10.3390/molecules16043371

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


1. Introduction

Rhodiola rosea L. has been widely used for a long time in Traditional Chinese Medicine. Salidroside (р-hydroxyphenethyl-β-D-glucoside, C14H20O7, 300.30), as shown in Figure 1, has been identified as the most potent ingredient in this medicinal plant [1]. Some studies have shown that salidroside possesses various pharmacological functions, including anti-aging [2], anti-cancer [3,4,5], anti-viral [6,7,8], anti-inflammatory [9], neuroprotective [10,11], hepatoprotective [9], cardiomyocytes protective [12,13], anti-diabetic [14] and antioxidant effects [15,16].
Figure 1

Structure of salidroside.

Oxidative damage, mediated by reactive oxygen species (ROS) has been thought as a major cause of atherosclerosis, cancer, liver disorder and the aging process [17]. In previously studies, people found that the antioxidant mechanism included [Ca2+]i and NO signaling pathways [18,19], thus it might involve the 3’-5’-cyclic adenosine monophosphate (cAMP)/3’-5’-cyclic guanosine monophosphate (cGMP)-dependent signaling pathway. To the best of our knowledge, no one has investigated the role of cAMP/cGMP in the antioxidant effects of salidroside, so the objective of the present paper was to examine the effects of salidroside on H2O2-induced oxidative damage, cAMP, cGMP; [Ca2+]i and ROS levels in HL-7702 cells to determine whether the cAMP/cGMP pathway participate in the antioxidant effects of salidroside. Our results would be benefitial for development of salidroside as a potential agent for treatment of oxidative stress-related diseases. Structure of salidroside.

2. Results and Discussion

2.1. Protective Effect of Salidroside on H2O2-Induced Cell Damage

The protective effect of salidroside on H2O2-induced cell damage as determined by the MTT assay is shown in Figure 2. Incubating with H2O2(0.5 mM) for 100 min induced significant cell damage. Pretreatment with salidroside (0.03, 0.05, 0.1 μg/mL) could attenuate H2O2-induced cell damage in a dose-dependent manner (p < 0.05), though it couldn’t restore the damaged cells totally. Data are expressed as mean ± S.D. (n = 4). # p < 0.05 and ## p < 0.01 compared with Control.
Figure 2

Protective effect of salidroside on H2O2-induced cell damage. Cells were treated with salidroside followed by H2O2 as described in 2.2 and cell viability was determined by MTT assay.

2.2. Salidroside Inhibited H2O2-Induced [Ca2+]i Elevation

We examined the effect of salidroside on [Ca2+]i. We found that incubating with H2O2(0.5 mM) for 100 min induced a significant [Ca2+]i elevation, while pre-incubation with salidroside dose dependently suppressed the elevation of [Ca2+]i (Figure 3). Data are expressed as mean ± S.D. (n = 4). * p < 0.05 and ** p < 0.01 compared with Control; # p < 0.05 and ## p < 0.01 compared with H2O2 group.
Figure 3

Salidroside inhibited H2O2-induced [Ca2+]i elevation (Recorded by inverted fluorescence microscope, Motic AE31 200×). (a). Control; (b). H2O2; (c). 0.03 μg/mL salidroside + H2O2; (d). 0.05 μg/mL salidroside + H2O2; (e). 0.1 μg/mL salidroside + H2O2; (f). Statistical analysis of fluorescence intensity data with Motic Advanced Images 3.2 software (China). Cells were treated with salidroside followed by H2O2 as described in 2.2. and [Ca2+]i levels were determined with Fluo-3/AM fluorescent dye.

Protective effect of salidroside on H2O2-induced cell damage. Cells were treated with salidroside followed by H2O2 as described in 2.2 and cell viability was determined by MTT assay. Salidroside inhibited H2O2-induced [Ca2+]i elevation (Recorded by inverted fluorescence microscope, Motic AE31 200×). (a). Control; (b). H2O2; (c). 0.03 μg/mL salidroside + H2O2; (d). 0.05 μg/mL salidroside + H2O2; (e). 0.1 μg/mL salidroside + H2O2; (f). Statistical analysis of fluorescence intensity data with Motic Advanced Images 3.2 software (China). Cells were treated with salidroside followed by H2O2 as described in 2.2. and [Ca2+]i levels were determined with Fluo-3/AM fluorescent dye.

2.3. Effects of Salidroside on the Formation of cAMP and cGMP

We investigated the effects of salidroside on the level of cAMP/cGMP. As shown in Figure 4, H2O2 decreased the levels of cAMP (Figure 4a) and cGMP (Figure 4b) in HL-7702 cells. The decreased level of cAMP was restored by treatment with salidroside, while the decreased level of cGMP was not changed. It showed that salidroside exerts antioxidant effects by cAMP, not cGMP. Data are expressed as absorbance density (OD) and presented as mean ± S.D. (n = 4). * p < 0.05 and ** p < 0.01 compared with Control; # p < 0.05 and ## p < 0.01 compared with H2O2 group.
Figure 4

(a). Effect of salidroside on cAMP level in cells; (b). Effect of salidroside on cGMP level in cells. Cells were treated with salidroside followed by H2O2 as described in 2.2.Contents of cAMP and cGMP were measured using human cyclic adenosine monophosphate Elisa kits and human cyclic guanosine monophosphate Elisa kits respectively.

(a). Effect of salidroside on cAMP level in cells; (b). Effect of salidroside on cGMP level in cells. Cells were treated with salidroside followed by H2O2 as described in 2.2.Contents of cAMP and cGMP were measured using human cyclic adenosine monophosphate Elisa kits and human cyclic guanosine monophosphate Elisa kits respectively.

2.4. Salidroside Inhibited H2O2-Induced ROS Elevation

We examined the effect of salidroside on intracellular ROS. We found that incubating with H2O2(0.5 mM) for 100 min induced ROS elevation significantly, while pre-incubation with salidroside dose dependently suppressed the elevation of ROS (Figure 5). Statistical analysis of fluorescence intensity data with Motic Advanced Images 3.2 software. Data were expressed as mean ± S.D. (n = 4). * p < 0.05 and ** p < 0.01 compared with Control; # p < 0.05 and ## p < 0.01 compared with H2O2 group.
Figure 5

Salidroside inhibited H2O2-induced ROS elevation (Recorded by inverted fluorescence microscope, Motic AE31 200×). (a). Control; (b). H2O2; (c). 0.03 μg/mL salidroside + H2O2; (d). 0.05 μg/mL salidroside + H2O2; (e). 0.1 μg/mL salidroside + H2O2; (f). Statistical analysis of fluorescence intensity data with Motic Advanced Images 3.2 software. Cells were treated with salidroside followed by H2O2 as described in 2.2.

Salidroside inhibited H2O2-induced ROS elevation (Recorded by inverted fluorescence microscope, Motic AE31 200×). (a). Control; (b). H2O2; (c). 0.03 μg/mL salidroside + H2O2; (d). 0.05 μg/mL salidroside + H2O2; (e). 0.1 μg/mL salidroside + H2O2; (f). Statistical analysis of fluorescence intensity data with Motic Advanced Images 3.2 software. Cells were treated with salidroside followed by H2O2 as described in 2.2.

2.5. Discussion

Today, oxidative damages caused by ROS and oxidative stress play important roles in many diseases, such as endocrine disruption [18]. H2O2, a major source of ROS, has been used in many studies to trigger oxidative damage [19]. In order to further studying antioxidant mechanism of salidroside, we investigated the effects of salidroside on H2O2-induced oxidative damage, cAMP, cGMP; [Ca2+]i and ROS level in HL-7702 cells. In this paper, we used H2O2 0.5 mM to trigger oxidative damage in HL-7702 cells. Incubating with H2O2 for 100 min induced significant cell damage. Salidroside (0.03, 0.05, 0.1 μg/mL) could attenuate H2O2-induced damage in a dose-dependent manner. It is suggested that salidroside at dose of 0.03, 0.05, 0.1 μg/mL could efficiently protect cells from oxidative damage. There is a mutual relationship between calcium and ROS signaling, which affects the local Ca2+ homeostasis [20]. H2O2 induced an [Ca2+]i rise which could still be evoked upon [Ca2+]i withdrawal and mitochondrial uncoupling [21]. In our research, 0.5 mM H2O2 successfully increased the level of [Ca2+]i in HL-7702 cells. [Ca2+]i levels are critical to cell life and changes in [Ca2+]i will affect matrix synthesis, as well as other functions [22]. In this experiment, salidroside inhibited H2O2-induced [Ca2+]i and ROS level and might be used in Ca2+ overloading disease. cAMP is one of the most important second messengers in regulating a wide variety of cellular events and processes, such as metabolism, gene expression, cell division, migration, exocytosis and secretion. In non-excitable cells the fluctuations of [Ca2+]i and [cAMP]i are often interrelated and linked via adenylate cyclase or phosphodiesterase [23]. Elevation of the cAMP level will decrease the [Ca2+]i, and our result is consistent with this. The increased level of cAMP participates in activating PKA and consequently this enzyme phosphorylates its substrate proteins. Thus, the increased level of cAMP is linked to the activation of PKA [24]. Salidroside influenced H2O2-induced cAMP level, so it might be linked PKA-mediated phosphorylation. cGMP is an important secondary messenger synthesized by the guanylyl cyclases and is also included in many cellular events and processes. It is believed that cGMP is produced via the activation of guanylate cyclase in the presence or absence of NO. NO is produced by the activation of NOS and affect the formation of cGMP. cGMP could affect [Ca2+]i through direct inhibition of L-type Ca2+ channels [15]. cAMP and cGMP both are regulators of NO [25]. Salidroside couldn’t influence cGMP level, so the change of NO may be mediated via cAMP-depend pathway. In the experiment, we found that salidroside attenuated H2O2-induced cell damage, inhibited H2O2-induced [Ca2+]i elevation, scavenged ROS at low dose through cAMP-dependent pathway. These findings suggested that antioxidant protection of salidroside was associated with the cAMP-dependent pathway and decrease of [Ca2+]i and ROS levels.

3. Experimental

3.1. Materials

Salidroside (standard material, purity >98%) was purchased from the National Institute for the Control of Pharmaceutical and Biological Products. 3-[4,5-Dimethyl-2-thiazolyl]-2,5-diphenyl-2-tetrazolium bromide (MTT) was purchased from Sigma (USA). Fluo-3/AM was obtained from Dojin Laboratories (Japan). 5-(and-6)-Chloromethyl-2’,7’-dichlorodihydrofluorescein diacetate, acetyl ester (CM-H2DCFDA) was obtained from Invitrogen (Molecular Probe), USA. RPMI 1640 was obtained from Gibco (USA). Human cyclic guanosine monophosphate ELISA kit and Human cyclic adenosine monophosphate ELISA kit were obtained from Blue Gene (Shanghai, China). FBS was obtained from Hangzhou (China). All other reagents were from commercial suppliers and of standard biochemical quality.

3.2. Protective Effect of Salidroside on H2O2-Induced Cell Damage

The human hepatocyte HL-7702 was obtained from SGST (China). The protective effect of salidroside was assessed by the MTT assay. Briefly, cells seeded on 96-well culture plates at 5 × 104/ well were incubated with salidroside for 24 h. Following exposure to H2O2 (0.5 mM) for 100 min, the MTT solution (10 μL, 5 mg/mL) was added into each well and made the final concentration 0.5 mg/mL, and then the plates were incubated for an additional 2 h. After the medium was removed, DMSO (100 μL) was added into each well before reading the microplates at 570 nm. Cell viability was expressed as absorbance density (OD).

3.3. Determination of [Ca2+]i

The [Ca2+]i was determined using Fluo-3/acetoxymethyl ester (Fluo-3/AM), described previously with slight modification [26]. Briefly, cells were loaded for 20 min at 37 °C with 20 μM Fluo-3/AM containing 1 μM pluronic acid F-127 for proper dispersal and 0.25 mM sulfinpyrazone, to inhibit the leakage of the Fluo-3 dye. Shortly before use, a sample of loaded cells was washed with Krebs-Ringer-Hepes (KRH) buffer (130 mM NaCl, 1.3 mM KCl, 2.2 mM CaCl2, 1.2 mM MgSO4, 1.2 mM KH2PO4, 10 mM Hepes, 10 mM glucose, pH 7.4), to remove nonhydrolyzed Fluo-3/AM. Fluorescence measurements were performed using an inverted fluorescence microscope (Motic AE31invert, Xiamen, China).

3.4. Measurement of cAMP and cGMP

Cells (5 × 104 /mL) were pre-incubated with various concentrations of salidroside for 48 h at 37 °C in 24-well culture plates, then incubated with H2O2 for 100 min. cAMP and cGMP were measured using the ELISA kits according to the manufacturer’s instructions. The levels of cAMP and cGMP were expressed by absorbance density (OD).

3.5. Measurement of ROS

The intracellular ROS levels of cells were determined using CM-H2DCFDA assay [26]. For these experiments, cells were incubated with phosphate-buffered saline (PBS) and 5 mM CM-H2DCFDA. As a control, cells were incubated with PBS only. As a positive control, cells were incubated with PBS, 5 mM CM-H2DCFDA, and 0.5 mM H2O2. After a 100 min incubation period with 0.5 mM H2O2, cells were trypsinized, washed, and resuspended in PBS. The levels of fluorescence intensity were immediately detected using an inverted fluorescent microscope (Motic AE31invert, Xiamen, China).

3.6. Statistical Analysis

All data were shown as means ± S.D. (standard deviation of the mean) Statistical analyses were performed using Student’s t-test and one-way analysis of variance (ANOVA). p < 0.05 was considered as statistically significant.

4. Conclusions

The data reported here firstly suggested that the antioxidant effects of salidroside were associated with down-regulation of [Ca2+]i, ROS and at least partly via cAMP-dependent pathway.
  25 in total

1.  Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells.

Authors:  Li Zhang; Huixin Yu; Xincan Zhao; Xiufeng Lin; Chen Tan; Guoxian Cao; Zhengwu Wang
Journal:  Neurochem Int       Date:  2010-07-06       Impact factor: 3.921

2.  Activity of compounds from Chinese herbal medicine Rhodiola kirilowii (Regel) Maxim against HCV NS3 serine protease.

Authors:  Guoying Zuo; Zhengquan Li; Lirong Chen; Xiaojie Xu
Journal:  Antiviral Res       Date:  2007-06-26       Impact factor: 5.970

3.  Protective effects of salidroside against acetaminophen-induced toxicity in mice.

Authors:  Yan-Ling Wu; Dong-Ming Piao; Xue-Hua Han; Ji-Xing Nan
Journal:  Biol Pharm Bull       Date:  2008-08       Impact factor: 2.233

4.  [Effect of salidroside on salivary adenoid cystic carcinoma cells in vitro].

Authors:  Mei-Hua Li; Gui-Zhen Zhang; Yi-Shu Wang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2008-06

5.  The influence of Rhodiola quadrifida 50% hydro-alcoholic extract and salidroside on tumor-induced angiogenesis in mice.

Authors:  E Skopińska-Rózewska; M Malinowski; A Wasiutyński; E Sommer; M Furmanowa; M Mazurkiewicz; A K Siwicki
Journal:  Pol J Vet Sci       Date:  2008       Impact factor: 0.821

6.  Cardioprotection of salidroside from ischemia/reperfusion injury by increasing N-acetylglucosamine linkage to cellular proteins.

Authors:  Tiejun Wu; Heping Zhou; Zhenxiao Jin; Shenghui Bi; Xiuling Yang; Dinghua Yi; Weiyong Liu
Journal:  Eur J Pharmacol       Date:  2009-04-17       Impact factor: 4.432

7.  Salidroside inhibits H2O2-induced apoptosis in PC12 cells by preventing cytochrome c release and inactivating of caspase cascade.

Authors:  Lei Cai; Hua Wang; Qin Li; Yunfei Qian; Wenbing Yao
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2008-09       Impact factor: 3.848

Review 8.  SR/ER-mitochondrial local communication: calcium and ROS.

Authors:  György Csordás; György Hajnóczky
Journal:  Biochim Biophys Acta       Date:  2009-06-13

9.  H(2)O(2)-mediated modulation of cytosolic signaling and organelle function in rat hippocampus.

Authors:  Florian J Gerich; Frank Funke; Belinda Hildebrandt; Martin Fasshauer; Michael Müller
Journal:  Pflugers Arch       Date:  2009-05-10       Impact factor: 3.657

10.  Imaging cytoplasmic cAMP in mouse brainstem neurons.

Authors:  S L Mironov; E Skorova; G Taschenberger; N Hartelt; V O Nikolaev; M J Lohse; S Kügler
Journal:  BMC Neurosci       Date:  2009-03-27       Impact factor: 3.288

View more
  5 in total

1.  Rejuvenating activity of salidroside (SDS): dietary intake of SDS enhances the immune response of aged rats.

Authors:  Linlin Lu; Jiangshui Yuan; Shicui Zhang
Journal:  Age (Dordr)       Date:  2012-02-26

2.  Concentration-Dependent Effects of Rhodiola Rosea on Long-Term Survival and Stress Resistance of Yeast Saccharomyces Cerevisiae: The Involvement of YAP 1 and MSN2/4 Regulatory Proteins.

Authors:  Maria M Bayliak; Nadia I Burdyliuk; Lilia I Izers'ka; Volodymyr I Lushchak
Journal:  Dose Response       Date:  2013-06-04       Impact factor: 2.658

3.  Time-dependent effects of late-onset dietary intake of salidroside on lifespan and age-related biomarkers of the annual fish Nothobranchius guentheri.

Authors:  Xia Wang; Xiaoyuan Du; Yang Zhou; Su Wang; Feng Su; Shicui Zhang
Journal:  Oncotarget       Date:  2018-01-04

4.  Combined Transcriptomics and Metabolomics Analyses in Grass Carp Under Anesthetic Stress.

Authors:  Tianwei Wang; Yali Wang; Xueting Liu; Xiaoning Gao; Kun Hu
Journal:  Front Cell Infect Microbiol       Date:  2022-07-11       Impact factor: 6.073

Review 5.  Rosenroot (Rhodiola): Potential Applications in Aging-related Diseases.

Authors:  Wei Zhuang; Lifeng Yue; Xiaofang Dang; Fei Chen; Yuewen Gong; Xiaolan Lin; Yumin Luo
Journal:  Aging Dis       Date:  2019-02-01       Impact factor: 6.745

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.